A Study to Evaluate Rivoceranib Plus Best Supportive Care Compared to Placebo Plus Best Supportive Care in Participants With Gastric Cancer

Clinical trial NCT03042611 · COMPLETED

Trial details

NCT number: NCT03042611
Sponsor: Elevar Therapeutics
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Gastric Cancer Gastric Adenocarcinoma

Start date: 2017-03-14
Primary completion: 2019-02-15
Enrollment: 460

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.